Researchers report improved outcomes in chronic rhinosinusitis with nasal polyps, indicating the importance of infection control.
ESS and dupilumab both provide meaningful benefit in severe CRSwNP, with distinct temporal response patterns. Reduced exacerbations and bacterial infections-particularly S. aureus-were associated with more favorable disease trajectories, underscoring the importance of infection control in individualized treatment selection.
No takes yet. Share an insight, caveat, or question.
Narendran et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: